NYU LANGONE HEALTH / NYU GROSSMAN SCHOOL OF MEDICINE Researchers at NYU Grossman School of Medicine and Janssen Biotech, Inc. have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients. Experiments demonstrated that SM1B74, an...